Certificate of Analysis (COA) View the laboratory certificate for this product [ View COA ]

Pure Tirzepatide

R 799.00

Strength: 15mg

Pure Tirzepatide is a research-grade synthetic peptide supplied as a lyophilised powder for laboratory and scientific research applications.

Tirzepatide is a dual GIP and GLP-1 receptor agonist investigated extensively in metabolic and endocrine research. Research focuses on GIP and GLP-1 signalling, glucose-dependent insulin pathways, glucagon regulation, appetite-related signalling, energy balance and metabolic processes.

COA: https://verify.janoshik.com/tests/200202-TIRZEPATIDE_30mg_NXZLM8F8PA7E

This research presentation is supplied with PURE Labs' stated 99% purity specification and third-party verification.

Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.

For laboratory and scientific research use only. Not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of disease.

Key Features

• Research Grade • 60mg reference strength • 99% Purity • Third-Party Verified • Lyophilised powder • GIP / GLP-1 dual receptor agonist • Laboratory research use

Dosage & Usage

CAS: 2023788-19-2
Molecular Formula: C225H348N48O68
Molecular Weight: 4813.44 g/mol
Research classification: GIP / GLP-1 dual receptor agonist; metabolic and endocrine research.

Scientific literature includes research into Tirzepatide's dual GIP and GLP-1 receptor activity and associated metabolic signalling pathways.

FAQ's & Tips

What is Tirzepatide?
Tirzepatide is a synthetic peptide studied as a dual GIP and GLP-1 receptor agonist.

What is the reference strength?
60mg.

What is Tirzepatide researched for?
Research includes GIP and GLP-1 receptor signalling, glucose metabolism, insulin and glucagon pathways, appetite-related signalling and metabolic research.

How is it supplied?
Lyophilised peptide powder.

Is Tirzepatide intended for human use?
No. This product is supplied strictly for laboratory and scientific research.

Research

Tirzepatide is a synthetic peptide engineered to activate both the GIP and GLP-1 receptors. Research has examined downstream effects on glucose-dependent insulin secretion, glucagon regulation, appetite-related signalling and metabolic control. Clinical studies have established substantial pharmacologic activity, while this product is presented here strictly as a research material. For laboratory research use only.

Reviews